Compounds > ursodeoxycholic acid
Page last updated: 2024-08-23

ursodeoxycholic acid and Hepatic Encephalopathy

ursodeoxycholic acid has been researched along with Hepatic Encephalopathy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; Floreani, A; Goet, JC; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; Verhelst, X1
Jorgensen, R; Lindor, KD; Momah, N; Silveira, MG; Sinakos, E1
Bianchi, G; Gatta, A; Iervese, T; Magalotti, D; Marchesini, G; Merkel, C; Pisi, E; Zoli, M1

Other Studies

3 other study(ies) available for ursodeoxycholic acid and Hepatic Encephalopathy

ArticleYear
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
    The American journal of gastroenterology, 2018, Volume: 113, Issue:2

    Topics: Adult; Aged; Ascites; Aspartate Aminotransferases; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Esophageal and Gastric Varices; Europe; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Incidence; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; North America; Platelet Count; Population Growth; Prognosis; Proportional Hazards Models; Risk Factors; Ursodeoxycholic Acid

2018
Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:5

    Topics: Alkaline Phosphatase; Ascites; Bilirubin; Biomarkers; Cholagogues and Choleretics; Clinical Trials as Topic; Disease Progression; Endpoint Determination; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Varicose Veins

2012
Prognostic significance of portal hemodynamics in patients with compensated cirrhosis.
    Journal of hepatology, 1993, Volume: 17, Issue:1

    Topics: Adult; Aged; Blood Flow Velocity; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Portal System; Portal Vein; Probability; Prognosis; Proportional Hazards Models; Regional Blood Flow; Serum Albumin; Survival Analysis; Ultrasonography; Ursodeoxycholic Acid

1993